(Part 2 of 6) Substance Use Disorder (SUD) 101: How Should We Care For SUD in Patients With HIV?
Overview Assessment of Needs Drug Enforcement Agency certificate holders will be required to complete 8 hours of training on opioids, substance use disorders (SUDs), and pain management as of June 27th, 2023. The IAS–USA is excited to support you in meeting these new requirements with a free, 6-part webinar series comprising 8 hours of (more…)
Doxy-PEP: Who, When, and How?
Overview Assessment of Needs Given the increasing burden of gonorrhea, chlamydia, and syphilis infections in the US, effective tools are needed to fight against bacterial sexually transmitted infections (STIs). Doxycycline postexposure prophylaxis (doxy-PEP) is a sexual-health strategy that shows considerable promise in this endeavor. Drug formulations and recommendations for use continue to evolve, particularly (more…)
(Part 3 of 6) Substance Use Disorder: Initiating Buprenorphine in the Fentanyl Era and Other Treatment Considerations in Patients With Opioid Use Disorder and HIV
Overview Assessment of Needs Substance use disorder, including the misuse of opioids, may disproportionately affect people with HIV. It is essential that clinicians who treat patients with HIV recognize the signs of opioid use disorder and understand the current treatment options and challenges. Drug Enforcement Agency certificate holders are now required to complete 8 (more…)
Latest Update on Urgent Virus Outbreaks: October 2023
Program Description The IAS–USA is pleased to welcome guest discussant Katelyn K. Jetelina, MPH, PhD, epidemiologist, data scientist, and author of the popular Your Local Epidemiologist (YLE) newsletter. Dr Jetelina joins moderator Paul Volberding, MD, and discussants Peter Chin-Hong, MD, and Carlos del Rio, MD. IAS–USA Dialogues (formerly COVID-19 Dialogues) were created to address an urgent need for reliable scientific information, with (more…)
Cardiovascular Disease Prevention in Patients With HIV: The REPRIEVE Trial
Overview Assessment of Needs The primary results of the REPRIEVE (Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults) trial were published in the New England Journal of Medicine in July 2023 and show that the statin drug pitavastatin calcium lowers the risk of heart disease in people (more…)
Respiratory Syncytial Virus and Influenza Infections: New Immunization Approaches for Children
Overview Assessment of Needs Respiratory syncytial virus (RSV) and influenza are viruses associated with high mortality in children. Children at risk include the very young (<2 years of age) and those with immunocompromising conditions, such as HIV. This webinar, led by Yvonne Maldonado, MD, will discuss the latest science and recommendations for the prevention (more…)
Implementation of Long-Acting Drugs for Treatment and Prevention of HIV
Last Modified: Program Description This half-day virtual course will include an overview of the challenges in the implementation of long-acting drugs for the treatment and prevention of HIV and explore the latest research on the use of long-acting drugs for the treatment and prevention of (more…)
HIV 101: Initial Assessment, Initiation of Antiretroviral Therapy, and Monitoring of People With Newly Diagnosed HIV
Overview Assessment of Needs A firm grasp of the basics of clinical care for patients with HIV is essential for practitioners in Ryan White HIV/AIDS-funded clinics and programs who are new to HIV care. In this webinar, experts in the field will describe the core principles of HIV management, (more…)
(Part 4 of 6) Substance Use Disorder: Alcohol and Tobacco Use Disorders in Patients With HIV
Overview Assessment of Needs Substance use disorders, including alcohol and tobacco use disorders, may disproportionately affect people with HIV. It is essential that clinicians who treat patients with HIV recognize the signs of alcohol and tobacco use disorder and understand the current treatment options and challenges. Drug Enforcement Agency certificate holders are now required (more…)